BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST

被引：0
|
作者：
Ephrem, Georges [1 ]
Guenoun, Jonathan [1 ]
Kim, Michael [1 ]
Jauhar, Rajiv [1 ]
Meraj, Perwaiz [1 ]
机构：
[1] North Shore LIJ Hlth Syst, Hofstra North Shore LIJ Sch Med, Manhasset, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60115-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1139-094
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [1] BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION: A COMPARISON OF ACUTE ADVERSE OUTCOMES
    Meraj, Perwaiz M.
    Doshi, Rajkumar
    Patel, Amitkumar
    George, Bhavitha
    Kaur, Lakhbir
    Mozawalla, Fatima
    Bhiuya, Tanzim
    Jauhar, Rajiv
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 268 - 268
  • [2] BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST
    Ephrem, Georges
    Guenoun, Jonathan
    Kim, Michael
    Jauhar, Rajiv
    Meraj, Perwaiz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A66 - A66
  • [3] Bivalirudin versus Heparin Monotherapy in Percutaneous Coronary Intervention Patients: a Comparison of Acute Adverse Outcomes and Long Term Mortality
    Ephrem, Georges
    Kim, Michael C.
    Jauhar, Rajiv
    Meraj, Perwaiz M.
    CIRCULATION, 2014, 130
  • [4] Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention
    Rehmani, Ahmed
    Judkins, Chris
    Lee, Edmund
    Nguyen, Michael
    Whelan, Alan
    Schultz, Carl
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [5] Meta-Analysis Comparing Bivalirudin Versus Heparin Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention
    Bertrand, Olivier F.
    Jolly, Sanjit S.
    Rao, Sunil V.
    Patel, Tejas
    Belle, Loic
    Bernat, Ivo
    Parodi, Guido
    Costerousse, Olivier
    Mann, Tift
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (04): : 599 - 606
  • [6] BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Farag, Mohamed
    Gorog, Diana
    Srinivasan, Manivannan
    HEART, 2015, 101 : A9 - A9
  • [7] Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
    Patel, Hitcn
    Garris, Rana
    Bhutani, Suchit
    Shah, Priyank
    Rampal, Upamanyu
    Vasudev, Rahul
    Melki, Gabriel
    Abu Ghalyoun, Bader
    Virk, Hartaj
    Bikkina, Mahesh
    Shamoon, Faycz
    CARDIOLOGY RESEARCH, 2019, 10 (05) : 278 - 284
  • [8] Bivalirudin versus heparin with primary percutaneous coronary intervention
    Venetsanos, Dimitrios
    Lawesson, Ofia Sederholm
    James, Stefan
    Koul, Sasha
    Erlinge, David
    Swahn, Eva
    Alfredsson, Joakim
    AMERICAN HEART JOURNAL, 2018, 201 : 9 - 16
  • [9] Cost minimization analysis of bivalirudin versus heparin plus planned abxicimab in patients undergoing percutaneous coronary intervention
    Cequier, A.
    Moris, C.
    Badia, X.
    Lara, N.
    VALUE IN HEALTH, 2006, 9 (06) : A348 - A349
  • [10] Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention
    Centurion, Osmar Antonio
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2016, 10 : 122 - 129
12345